New app aims to shield breast cancer Patients' hearts from chemo damage

NCT ID NCT06518200

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a personalized program supported by a mobile app to prevent heart damage caused by breast cancer treatments. Researchers will enroll 102 women recently diagnosed with early-stage breast cancer who are at risk for heart side effects. The program uses artificial intelligence to tailor daily activities and monitor heart health, aiming to improve quality of life and reduce long-term risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Granada

    Granada, 18016, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.